EdgarLookup

Ventas, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Ventas, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
1.3%
Profit Margin
Net income ÷ revenue
0.3%
Return on Assets
Net income ÷ assets
1.17x
Debt-to-Equity
Total liabilities ÷ equity
+18.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.83B Feb 6, 2026
FY2025 Dec 31, 2024 $4.92B Feb 6, 2026
FY2025 Dec 31, 2023 $4.50B Feb 6, 2026
FY2024 Dec 31, 2022 $4.13B Feb 13, 2025
FY2023 Dec 31, 2021 $3.83B Feb 15, 2024
FY2020 Dec 31, 2020 $921.17M Feb 23, 2021
FY2020 Sep 30, 2020 $918.94M Feb 23, 2021
FY2020 Jun 30, 2020 $943.20M Feb 23, 2021
FY2020 Mar 31, 2020 $1.01B Feb 23, 2021
FY2020 Dec 31, 2019 $996.00M Feb 23, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2010 Dec 31, 2010 $77.58M Mar 1, 2011
FY2010 Sep 30, 2010 $57.90M Mar 1, 2011
FY2010 Jun 30, 2010 $58.07M Mar 1, 2011
FY2010 Mar 31, 2010 $52.62M Mar 1, 2011
FY2010 Dec 31, 2009 $54.08M Mar 1, 2011
FY2010 Sep 30, 2009 $49.81M Mar 1, 2011
FY2010 Jun 30, 2009 $88.38M Mar 1, 2011
FY2010 Mar 31, 2009 $74.23M Mar 1, 2011
FY2010 Dec 31, 2008 $222.60M Mar 1, 2011
FY2009 Dec 31, 2007 $273.68M Feb 19, 2010

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $27.59B Feb 6, 2026
FY2025 Dec 31, 2024 $26.19B Feb 6, 2026
FY2024 Dec 31, 2023 $24.73B Feb 13, 2025
FY2023 Dec 31, 2022 $24.16B Feb 15, 2024
FY2022 Dec 31, 2021 $24.72B Feb 10, 2023
FY2021 Dec 31, 2020 $23.93B Feb 18, 2022
FY2020 Dec 31, 2019 $24.69B Feb 23, 2021
FY2019 Dec 31, 2018 $22.58B Feb 24, 2020
FY2018 Dec 31, 2017 $23.95B Feb 8, 2019
FY2017 Dec 31, 2016 $23.17B Feb 9, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.63B Feb 6, 2026
FY2025 Dec 31, 2024 $15.05B Feb 6, 2026
FY2024 Dec 31, 2023 $14.88B Feb 13, 2025
FY2023 Dec 31, 2022 $13.67B Feb 15, 2024
FY2022 Dec 31, 2021 $13.49B Feb 10, 2023
FY2021 Dec 31, 2020 $13.42B Feb 18, 2022
FY2020 Dec 31, 2019 $13.87B Feb 23, 2021
FY2019 Dec 31, 2018 $12.12B Feb 24, 2020
FY2018 Dec 31, 2017 $12.86B Feb 8, 2019
FY2017 Dec 31, 2016 $12.44B Feb 9, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.53B Feb 6, 2026
FY2025 Dec 31, 2024 $10.77B Feb 6, 2026
FY2024 Dec 31, 2023 $9.49B Feb 13, 2025
FY2023 Dec 31, 2022 $10.15B Feb 15, 2024
FY2022 Dec 31, 2021 $10.85B Feb 10, 2023
FY2021 Dec 31, 2020 $10.18B Feb 18, 2022
FY2020 Dec 31, 2019 $10.45B Feb 23, 2021
FY2019 Dec 31, 2018 $10.22B Feb 24, 2020
FY2018 Dec 31, 2017 $10.87B Feb 8, 2019
FY2017 Dec 31, 2016 $10.46B Feb 9, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 6, 2026
FY2025 Dec 31, 2024 0 Feb 6, 2026
FY2025 Dec 31, 2023 0 Feb 6, 2026
FY2024 Dec 31, 2022 0 Feb 13, 2025
FY2023 Dec 31, 2021 0 Feb 15, 2024
FY2020 Dec 31, 2020 0 Feb 23, 2021
FY2020 Sep 30, 2020 0 Feb 23, 2021
FY2020 Jun 30, 2020 0 Feb 23, 2021
FY2020 Mar 31, 2020 1 Feb 23, 2021
FY2020 Dec 31, 2019 0 Feb 23, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 6, 2026
FY2025 Dec 31, 2024 0 Feb 6, 2026
FY2025 Dec 31, 2023 0 Feb 6, 2026
FY2024 Dec 31, 2022 0 Feb 13, 2025
FY2023 Dec 31, 2021 0 Feb 15, 2024
FY2020 Dec 31, 2020 0 Feb 23, 2021
FY2020 Sep 30, 2020 0 Feb 23, 2021
FY2020 Jun 30, 2020 0 Feb 23, 2021
FY2020 Mar 31, 2020 1 Feb 23, 2021
FY2020 Dec 31, 2019 0 Feb 23, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $741.07M Feb 6, 2026
FY2025 Dec 31, 2024 $897.85M Feb 6, 2026
FY2024 Dec 31, 2023 $508.79M Feb 13, 2025
FY2023 Dec 31, 2022 $122.56M Feb 15, 2024
FY2022 Dec 31, 2021 $149.73M Feb 10, 2023
FY2021 Dec 31, 2020 $413.33M Feb 18, 2022
FY2020 Dec 31, 2019 $106.36M Feb 23, 2021
FY2019 Dec 31, 2018 $72.28M Feb 24, 2020
FY2018 Dec 31, 2017 $81.36M Feb 8, 2019
FY2017 Dec 31, 2016 $286.71M Feb 9, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.01B Feb 6, 2026
FY2025 Dec 31, 2024 $13.52B Feb 6, 2026
FY2024 Dec 31, 2023 $13.49B Feb 13, 2025
FY2023 Dec 31, 2022 $12.30B Feb 15, 2024
FY2022 Dec 31, 2021 $12.03B Feb 10, 2023
FY2021 Dec 31, 2020 $11.90B Feb 18, 2022
FY2020 Dec 31, 2019 $12.16B Feb 23, 2021
FY2019 Dec 31, 2018 $10.73B Feb 24, 2020
FY2018 Dec 31, 2017 $11.28B Feb 8, 2019
FY2017 Dec 31, 2016 $11.13B Feb 9, 2018